title: Clopidogrel with or without omeprazole in coronary disease.
authors.forename: David N
authors.initials: DN
authors.lastname: Juurlink
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology; D002626:Chemistry, Pharmaceutical; D000077144:Clopidogrel; D003324:Coronary Artery Disease / Q000188:drug therapy*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control; D006801:Humans; D009853:Omeprazole / Q000627:therapeutic use*; D000077402:Pantoprazole; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D054328:Proton Pump Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D010975:Platelet Aggregation Inhibitors; D054328:Proton Pump Inhibitors; D000077144:Clopidogrel; D000077402:Pantoprazole; D009853:Omeprazole; D013988:Ticlopidine